首页> 外文期刊>Genes, Chromosomes and Cancer >Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
【24h】

Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.

机译:急性髓性白血病中新型Runx1(AML1)易位伴侣基因SH3D19,YTHDf2和ZNF687的鉴定。

获取原文
获取原文并翻译 | 示例
       

摘要

Three patients diagnosed with acute myeloid leukemia (AML) with reciprocal 21q22/RUNX1(AML1) translocations involving chromosomes 1 and 4 were studied. Three novel RUNX1 translocation partner genes on 1q21.2 (ZNF687), 1p35 (YTHDF2), and 4q31.3 (SH3D19) were identified using a panhandle polymerase chain reaction and the 3' rapid amplification of cDNA ends method. The translocation events occurred between exons 3 and 7 of the RUNX1 gene. The partner gene breakpoints localized to the region in the partner gene with the highest Alu density, suggesting that Alus may contribute to the recombination events. Two out of three of the cases retained RUNX1's entire RUNT domain in the translocation, and RUNX1 mutations were absent in the fusion transcripts, confirmed by reverse transcription-polymerase chain reaction and sequencing analysis. SH3D19 encodes a cytoplasmic protein EBP known to suppress RAS-induced cellular transformation, which can be inhibited by nuclear recruitment. The t(4;21) created a hybrid RUNX1-EBP protein retaining RUNX1's DNA binding domain, which may result in nuclear localization of the chimeric protein and inhibition of EBP's RAS-suppressive functions. Future studies would be useful to further characterize these novel fusion protein products.
机译:研究了三例诊断为急性髓性白血病(AML)且涉及染色体1和4的21q22 / RUNX1(AML1)易位易位的患者。使用泛柄聚合酶链反应和cDNA末端3'快速扩增方法鉴定了1q21.2(ZNF687),1p35(YTHDF2)和4q31.3(SH3D19)上的三个新的RUNX1易位伴侣基因。易位事件发生在RUNX1基因的外显子3和7之间。伴侣基因断点位于伴侣基因中具有最高Alu密度的区域,表明Alus可能参与了重组事件。在三分之二的病例中,RUNX1的整个RUNT结构域保留在转位中,并且融合转录本中不存在RUNX1突变,这通过逆转录-聚合酶链反应和测序分析得以证实。 SH3D19编码一种已知可抑制RAS诱导的细胞转化的细胞质蛋白EBP,其可被核募集抑制。 t(4; 21)创建了一个保留了RUNX1的DNA结合域的杂化RUNX1-EBP蛋白,这可能导致嵌合蛋白的核定位并抑制EBP的RAS抑制功能。未来的研究将有助于进一步表征这些新型融合蛋白产物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号